arXiv:2605.15062cs.CV2026-05

用光学先验提升胶囊内镜对血管病变的识别能力

Training-Time Optical Priors for Wireless Capsule Endoscopy Classification: Hemoglobin-Aware Input Fusion with Cross-Vendor Evaluation

论文配图:Training-Time Optical Priors for Wireless Capsule Endoscopy Classification: Hemoglobin-Aware Input Fusion with Cross-Vendor Evaluation
图 1 · 摘自论文原文
  • 训练时注入血红蛋白光学先验,融合多通道输入增强模型感知
  • 在跨厂商数据集上,血管病变识别准确率提升近40%
  • 无需修改推理流程,可生成可解释热力图,适合临床部署

胃肠道癌症每年导致约340万例死亡,小肠病变在无线胶囊内镜(WCE)中易被漏诊。现有基于RGB的分类器将血红蛋白对比度与胆汁染色和光照衰减混淆,降低对淋巴管扩张等微小血管病灶的敏感性。本文提出一种物理启发的训练时框架,首次在WCE分类中引入基于蒙特卡洛模拟的血红蛋白先验,仅在训练阶段注入。在Kvasir-Capsule数据集(47,238帧,43名患者,11个可评估类别,患者独立划分)上,对比六次随机种子下仅使用RGB的EfficientNet-B0基线,测试了五通道输入融合、蒸馏版(推理仍用三通道RGB)、三流扩展模型(含时间Transformer与自编码残差流)。结果表明,输入融合使宏AUC从0.760升至0.783(5/6种子显著提升);蒸馏版达0.773;三流模型达0.804,较基线提升0.044(配对DeLong检验,p<0.0001)。淋巴管扩张的AUC从0.238升至0.337,方向一致。消融实验揭示参数化机制边界:仅空间-通道形式有效。在公开的Galar跨厂商数据集上进行零样本迁移,性能保留约60%提升。蒸馏版本可在纯RGB输入下部署,并生成免费可解释热力图。研究发布GalKva-2026,作为配对跨厂商基准。

原文摘要 · Abstract (English)

Gastrointestinal cancers cause approximately 3.4 million deaths annually, and early small-bowel lesions are easily missed at wireless capsule endoscopy (WCE). RGB-trained WCE classifiers conflate hemoglobin contrast with bile staining and illumination falloff, limiting sensitivity to small-vessel vascular findings such as Lymphangiectasia. We introduce a physics-informed framework that injects an analytic, Monte-Carlo-inspired hemoglobin prior into a standard classifier purely at training time -- to our knowledge the first use of an explicit optical light-transport prior in WCE classification. On Kvasir-Capsule (47,238 frames, 43 patients, 11 evaluable classes; patient-disjoint split) we evaluate, across six seeds against an RGB-only EfficientNet-B0 baseline, a five-channel input-fusion variant feeding the prior alongside RGB, a distillation variant that runs on plain three-channel RGB at inference, and a three-stream extension adding a temporal Transformer and an autoencoder-residual stream; we replicate across ResNet-18 and ConvNeXt-Tiny and assess cross-vendor zero-shot transfer on the public Galar cohort. Input fusion lifts cross-seed macro-AUC from 0.760 to 0.783 (5/6 seeds positive); distillation reaches 0.773; the three-stream model reaches 0.804 (+0.044 over baseline, paired DeLong p < 0.0001). Lymphangiectasia AUC rises from 0.238 to 0.337, sign-consistent across all six seeds. A four-variant ablation reveals a parameterization-mechanism boundary: only the spatial-channel form lifts. Cross-vendor zero-shot on Galar retains about 60% of the lift. The distillation variant deploys on plain RGB with a free interpretability heatmap, and we release GalKva-2026, a paired cross-vendor benchmark.

医学图像胶囊内镜光学先验可解释性

Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。